Spots Global Cancer Trial Database for Study of AMG 706 in Subjects With Advanced Gastrointestinal Stromal Tumors (GISTs)
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Study of AMG 706 in Subjects With Advanced Gastrointestinal Stromal Tumors (GISTs)
Official Title: An Open Label Study of AMG 706 in Subjects With Advanced Gastrointestinal Stromal Tumors (GISTs) Who Developed Progressive Disease or Relapsed While on Imatinib Mesylate
Study ID: NCT00089960
Conditions
Interventions
Study Description
Brief Summary: This study will determine the safety and effectiveness of AMG 706 in patients with advanced GIST.
Detailed Description: Expanded Access: Amgen provides expanded access for this clinical trial. Contact the Amgen Call Center (866-572-6436) for more information.
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Contact Details
Name: MD
Affiliation: Amgen
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
